Asked by: Clive Betts (Labour - Sheffield South East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans his Department has to consider transplants, including stem cell and bone marrow transplants, as part of the Getting It Right First Time programme.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
There are no current plans to consider transplants, including stem cell and bone marrow transplants, as part of the Getting It Right First Time programme. The Department is aware of challenges around the timely provision of well-matched stem cell donors, particularly for people from mixed heritage or ethnic minority backgrounds, and therefore instead intends to review the factors underlying this and the system supporting stem cell donation.
Asked by: Baroness Barker (Liberal Democrat - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure uninterrupted access to antiretroviral therapy for people living with HIV when they enter, transfer between, or leave prison, including provision of long-acting injectable treatments where appropriate.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The new HIV Action Plan, published on World AIDS Day on 1 December 2025, sets out how the Government will enable every level of the healthcare system to work together to engage everyone in prevention, testing, and treatment, tackling stigma, and reaching our ambition to end new HIV transmissions by 2030. This includes a dedicated action to deliver tailored and targeted HIV prevention, treatment, and care services to meet the needs of local populations and address inequalities, including the challenges of HIV prevention and care in prisoners.
People entering prison receive healthcare assessments on reception which identify current healthcare needs and treatment. This includes identifying people who are receiving treatment for HIV. The healthcare team will use processes for accessing critical medicines to arrange an urgent supply of HIV medicines from the specialist clinic if required. The healthcare team will then ensure a referral to the local HIV specialist team if the patient is in a prison, in a location which lies outside of the area covered by their current specialist. HIV services have clear processes used to promptly transfer care between specialists.
The UK Health Security Agency is working with regional partners to carry out an audit to understand the provision of HIV diagnosis, prevention, and care in English prisons.
Asked by: Helen Maguire (Liberal Democrat - Epsom and Ewell)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the Design for Life roadmap, what progress has been made in reducing NHS equipment wastage.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England has been working on reducing waste and its associated carbon since publication of the NHS Clinical Waste Strategy in 2023.
NHS England’s Estates Returns Information Collection (ERIC) is a mandatory annual data collection for all National Health Service trusts in England that captures waste metrics in waste type tonnages and not specific items of waste. ERIC figures to 2025 show a reduction of 41,000 tonnes of carbon.
The latest reporting year, 1 April 2024 to 31 March 2025, which covers the period during which the Design for Life Roadmap was launched, in October 2024, saw a reduction of 10,000 tonnes of carbon from waste.
To supplement this work, since publication of the roadmap, the Department has conducted a series of pilots across a range of different medical products and equipment, with most demonstrating waste savings, in carbon terms, from switching to reusable alternatives. The full report can be found on the Centre for Sustainable Healthcare’s website, who were our partner on these pilots, at the following link:
The Department is building on this work with a dedicated Priority Adoption Working Group, which includes clinical and procurement professionals, to identify the products with the strongest case for safe, immediate transitions to reusables across the NHS, to drive further waste, and cost, savings at scale. NHS England is supporting this work, alongside its own initiatives to reduce the overuse of products and waste. For example, through the Five years of a greener NHS: progress and forward look, the NHS has committed to reduce single-use glove and gown use by 25% by 2030, with further information available at the following link:
https://www.england.nhs.uk/long-read/five-years-greener-nhs-progress-forward-look/
Asked by: Jess Brown-Fuller (Liberal Democrat - Chichester)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with the Department of State for Education on the recognition of the Pathological Demand Avoidance profile within assessments for Autism Spectrum Disorder.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
My Rt Hon. Friend, the Secretary of State for Health and Social Care, has regular discussions on a wide range of matters, including with other departments.
Pathological Demand Avoidance (PDA) is most often understood as a characteristic of, or observed in, some autistic people, but professional consensus on its status is still required. PDA is not a recognised and ‘stand-alone’ diagnosis within the Diagnostic and Statistical Manual of Mental Disorders or the International Classification of Disease.
It is the responsibility of integrated care boards to make available appropriate provision to meet the health and care needs of their local population, including assessment services for autistic people, in line with National Institute for Health and Care Excellence (NICE) guidelines.
The NICE guideline Autism spectrum disorder in under 19s: recognition, referral and diagnosis, recommends that as part of autism assessments healthcare workers should consider PDA and carry out appropriate referrals.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to increase access to medication for people with IBD.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) is the independent body that makes recommendations on whether all new medicines and significant licence extensions for existing medicines should be routinely funded by the National Health Service in England based on an assessment of clinical and cost effectiveness. In the last three years, NICE has recommended five new drugs for the treatment of moderate to severe Crohn’s disease and ulcerative colitis, including upadacitinib, risankizumab, mirikizumab, etrasimod, and guselkumab. The NHS in England is legally required to fund medicines recommended by NICE, normally within three months of the publication of final guidance.
Asked by: Helen Maguire (Liberal Democrat - Epsom and Ewell)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the Design for Life roadmap, how much equipment has been diverted from waste since the roadmap was launched.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England has been working on reducing waste and its associated carbon since publication of the NHS Clinical Waste Strategy in 2023.
NHS England’s Estates Returns Information Collection (ERIC) is a mandatory annual data collection for all National Health Service trusts in England that captures waste metrics in waste type tonnages and not specific items of waste. ERIC figures to 2025 show a reduction of 41,000 tonnes of carbon.
The latest reporting year, 1 April 2024 to 31 March 2025, which covers the period during which the Design for Life Roadmap was launched, in October 2024, saw a reduction of 10,000 tonnes of carbon from waste.
To supplement this work, since publication of the roadmap, the Department has conducted a series of pilots across a range of different medical products and equipment, with most demonstrating waste savings, in carbon terms, from switching to reusable alternatives. The full report can be found on the Centre for Sustainable Healthcare’s website, who were our partner on these pilots, at the following link:
The Department is building on this work with a dedicated Priority Adoption Working Group, which includes clinical and procurement professionals, to identify the products with the strongest case for safe, immediate transitions to reusables across the NHS, to drive further waste, and cost, savings at scale. NHS England is supporting this work, alongside its own initiatives to reduce the overuse of products and waste. For example, through the Five years of a greener NHS: progress and forward look, the NHS has committed to reduce single-use glove and gown use by 25% by 2030, with further information available at the following link:
https://www.england.nhs.uk/long-read/five-years-greener-nhs-progress-forward-look/
Asked by: Liz Jarvis (Liberal Democrat - Eastleigh)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support research into Mast Cell Activation Syndrome; and what steps he is taking to improve training for NHS healthcare professionals in the diagnosis and management of that condition.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department funds research through the National Institute for Health and Care Research (NIHR). The NIHR funds clinical, public health, and social care research and works in partnership with the National Health Service, universities, local government, other research funders, patients, and the public, and the NIHR also funds global health research.
The NIHR welcomes funding applications for research into any aspect of human health and care, including mast cell activation syndrome. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. Further information is available at the following link:
https://www.nihr.ac.uk/get-involved/suggest-a-research-topic
NHS England Specialised Commissioning has published a Service Specification for Specialist Allergy Services, which covers the responsibilities of specialised commissioned providers with regard to patients with mastocytosis and related disorders. This includes the expectation for specialist allergy services to be provided by multidisciplinary teams, led by physicians with evidence of training and/or experience in the practice of allergy or immunology. Further information is available at the following link:
The management of service users with mastocytosis is provided by specialised allergy/immunology, dermatology, and haematology services. The lead clinician will vary at different centres, but specialist allergy input should be readily available.
Asked by: Carolyn Harris (Labour - Neath and Swansea East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve support and services for patients with Avoidant Restrictive Food Intake Disorder.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England continues to work with eating disorder services and local commissioners to improve access to assessment and treatment for people with a suspected eating disorder, including those presenting with avoidant restrictive food intake disorder (ARFID). Lessons from previous pilots commissioned to improve access to support and develop training on ARFID has contributed to this work.
Community children and young people’s eating disorder services across England provide assessment and treatment for eating disorders, including ARFID, and local areas are able to commission training and adapt care pathways to ensure services meet the needs of patients with this condition.
In January 2026, NHS England also updated guidance on children and young people's eating disorders, including ARFID, that seeks to strengthen early identification and intervention of eating disorders, whilst ensuring swift access to specialist community eating disorder services as soon as an eating disorder is suspected.
Whilst the guidance focuses on improving community pathways for children and young people, the national specialised adult service model continues to provide access to highly specialist inpatient treatment for adults with complex eating disorders, through the Specialised Adult Eating Disorder Units network. These units deliver multidisciplinary care that typically includes psychiatric assessment and treatment, psychological therapies, medical monitoring, dietetic support and structured rehabilitation, and can provide inpatient care for adults with severe and enduring eating disorders where required.
Integrated care boards are responsible for providing health and care services to meet the needs of their local populations.
Asked by: Alison Bennett (Liberal Democrat - Mid Sussex)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what consideration his Department has given to the potential merits of introducing financial support, including vouchers, for people with Coeliac disease who are unable to access gluten-free prescriptions.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Prescribing decisions are made by the responsible clinician, who is accountable for ensuring that prescribing is clinically appropriate and consistent with national and local guidance. NHS England’s guidance on prescribing gluten-free (GF) foods sets out a national framework for primary care, and integrated care boards (ICBs) are responsible for commissioning arrangements in their areas and for supporting general practices to prescribe in line with that framework, taking account of local population needs.
The national position in England remains that gluten free bread and mixes can be prescribed on the National Health Service for eligible people diagnosed with Coeliac disease. However, ICBs can restrict or end the prescribing of GF food. There are no plans to change the current arrangements or to introduce additional financial support, such as vouchers, for GF food.
Asked by: Peter Bedford (Conservative - Mid Leicestershire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how are musculoskeletal conditions being prioritised within the neighbourhood health framework.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Neighbourhood Health Framework is designed to provide clarity and consistency to integrated care boards (ICBs), local authorities, and their partners, in developing and scaling neighbourhood health.
The framework outlines the national minimum aims and objectives of Neighbourhood Health Services. This includes improving health outcomes with specific focus on high-priority cohorts, including people with frailty. Whilst frailty and musculoskeletal overlap, we recognise that many people with conditions affecting their joints, bones, and muscles across their life course are not frail.
It is important that reforms are locally led, as ICBs and local authorities are best placed to design services that make sense for their local populations. Local systems can choose to go further than the minimum aims set out in the framework, and this could include musculoskeletal services.
We know there are areas where we need to go further. Delivering a Neighbourhood Health Service will be an incremental process as local understanding develops and national reforms progress.